REG - Softcat PLC - Transaction in Own Shares

SoftcatAnnouncement

16/02/2026 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260216:nRSP0322Ta&default-theme=true

RNS Number : 0322T  Softcat PLC  16 February 2026

16 February 2026

 

 

Softcat plc ("Softcat" or "the Company")

 

Completion of Share Buyback Programme

 

 

Softcat plc announces that it has completed the share buyback programme,
announced on 8 January 2026 to repurchase up to £45 million of its ordinary
shares.

 

Under the terms of the programme, the Company repurchased a total of 3,352,161
ordinary shares for an aggregate consideration of £44,999,915, including
stamp duty and expenses. This represents 1.67% of the issued share capital of
the Company when the programme commenced. The volume weighted average price of
the shares repurchased was 1,333.082p. All shares purchased under the
programme have been cancelled.

 

Following the completion of the programme, the Company's issued share capital
consists of 196,840,451 ordinary shares. Therefore, the total number of voting
rights in the Company is 196,840,451.  The Company does not hold any shares
in treasury.

 

This figure may be used by shareholders as the denominator for calculations by
which they determine whether they are required to notify their interest in, or
a change to their interest in the Company under the FCA's Disclosure and
Transparency Rules.

 

This announcement will also be available on Softcat's website at:
https://www.softcat.com/about-us/investor-centre/regulatory-news
(https://www.softcat.com/about-us/investor-centre/regulatory-news)

 

 

For further information please contact:

 

Softcat plc

Luke Thomas, Company
Secretary
+ 44 (0) 1628 403 403

Michael Watts, Head of Investor Relations

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSBIGDDLBBDGLX



            Copyright 2019 Regulatory News Service, all rights reserved